Users' guide to detecting misleading claims in clinical research reports

被引:82
作者
Montori, VM
Jaeschke, R
Schünemann, HJ
Bhandari, M
Brozek, JL
Devereaux, PJ
Guyatt, GH [1 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada
[2] Jagiellonian Univ, Sch Med, Polish Inst Evidence Based Med, Krakow, Poland
[3] McMaster Univ, Dept Med, Hamilton, ON, Canada
[4] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7474期
关键词
D O I
10.1136/bmj.329.7474.1093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1093 / 1096
页数:6
相关论文
共 30 条
[11]  
Docherty M, 1999, BRIT MED J, V318, P1224
[12]   Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].
Geddes, J ;
Freemantle, N ;
Harrison, P ;
Bebbington, P .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376
[13]  
GREENHALGH T, 2001, READ PAPER
[14]   THE RHETORIC OF RESEARCH [J].
HORTON, R .
BRITISH MEDICAL JOURNAL, 1995, 310 (6985) :985-987
[15]   Prevention of end-stage renal disease due to type 2 diabetes. [J].
Hostetter, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :910-912
[16]  
Jaeschke R., 2002, USERSGUIDES MEDICAL, P187
[17]   Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis [J].
Johansen, HK ;
Gotzsche, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1752-1759
[18]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[19]   Pharmaceutical industry sponsorship and research outcome and quality: systematic review [J].
Lexchin, J ;
Bero, LA ;
Djulbegovic, B ;
Clark, O .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7400) :1167-1170B
[20]  
MANN H, J LIND LIB